The collaboration with Revvity resulted in the launch of their staining kit, tested and approved by ETAP-LAB!
Results of the strategic collaboration between ETAP-Lab and Revvity announced
We are proud to announce that ETAP-Lab, preclinical CRO expert in neuroscience, partnered with Revvity, leader in High Content Screening (HCS) solutions, to push the boundaries of discovery by combining their expertise and technology.
Revvity has just launched the staining kit for astrocyte differentiation – tested and approved by ETAP-LAB – specially designed for iPSC-derived neuronal models.
At ETAP-LAB, our teams contributed to this successful launch thanks to:
- our neuroscience expertise, delivering reliable and reproducible cellular models,
- the use of HCS technologies on our in vitro models of neurodegenerative diseases
- the careful selection of antibodies and the validation tests carried out on hiPSCs
Explore our platforms – Operetta CLS High Content Screening by Revvity: https://www.etap-lab.com/our-platforms/
Revvity’s product launch in details
The PhenoVue Astrocyte Differentiation Staining Kit offers a reliable solution for confirming the phenotype of astrocytes using a multiplex staining approach. PhenoVue™ reagents are suitable for high-content imaging applications. These brand-new preconfigured kits, containing dyes, reagents, and a detailed protocol, have been carefully tested and approved using ETAP-LAB’s expertise to accelerate workflows.
This is a reliable and easy-to-use solution for qualifying astrocyte differentiation and assessing activation states based on cellular morphology. Discover the kit in Revvity’s webiste.
